The EpiDerm Skin Irritation test (EpiDerm SIT) was developed (1, 2, 3) and validated (4, 5) for in vitro skin irritation testing of chemicals, including cosmetic and pharmaceutical ingredients. The EpiDerm SIT utilizes the 3D in vitro reconstructed human epidermal (RHE) model EpiDerm. The procedure described in this protocol allows for discrimination between irritants of GHS category 2 and non-irritants (6) . The test is performed over the course of a 4 day time period, consisting of pre-incubation, 60 minute exposure, 42 hour post-incubation and MTT viability assay. After tissue receipt and overnight pre-incubation (Day 0), tissues are topically exposed to the test chemicals (Day 1), which can be liquid, semi-solids, solid or wax. Three tissues are used for each test chemical, as well as for the positive control (5% aq. SDS solution), and a negative control (DPBS). Chemical exposure lasts for 60 minutes, 35 min of which the tissues are kept in an incubator at 37°C. The test substances are then removed from the tissue surface by an extensive washing procedure. The tissue inserts are blotted and transferred to fresh medium. After a 24 hr incubation period (Day 2), the medium is exchanged. The medium can be saved for further analysis of cytokines or other endpoints of interest. After the medium exchange, tissues are incubated for an additional 18 hours. At the end of the entire 42h post-incubation (day 3), the tissues are transferred into yellow MTT solution and incubated for 3 hours. The resultant purple-blue formazan salt, formed mainly by mitochondrial metabolism, is extracted for 2 hours using isopropanol. The optical density of the extracted formazan is determined using a spectrophotometer. A chemical is classified as an irritant if the tissue viability relative to the negative control treated tissues is reduced below 50%. This procedure can be used as full replacement of the in vivo rabbit skin irritation test for hazard identification and labeling of chemicals in line with EU regulations (7) .
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Video Link
The video component of this article can be found at https://www.jove.com/video/1366/ Protocol I. Tissue conditioning -Day 0 1 . Upon receipt of the EpiDerm EPI-200-SIT kit, check all the kit components for integrity (for kit details see Table of specific reagents and  equipment) . 2. For every three EpiDerm tissues, prepare one sterile 6-well plate pre-filled with 0.9 ml of assay medium. 3. Under sterile conditions, open the plastic bag containing the 24-well plate containing the EpiDerm tissues and remove the sterile gauze. 4. Use sterile forceps to remove each insert containing the EpiDerm tissue and place the insert in the empty 24-well plate. During this step, remove any remaining shipping agarose that adheres to the outer sides of the insert by gentle blotting on sterile filter paper. 5. Within the next 5 minutes, visually inspect the tissues. Do not use defective tissues or tissues which are completely covered with liquid. 6. Using a sterile cotton tip swab, carefully dry the surface of the tissues. Try not to touch the tissue directly -capillary effects are sufficient to remove the moisture from the tissue surface. 7. After drying the tissue surface, transfer three tissues to the top row of the 6-well plates pre-filled with 0.9 mL of assay medium. Release any air bubbles trapped underneath the inserts. 8. Place the 6-well plates containing the inserts into the incubator for a 60 ± 5 min pre-incubation at 37 ± 1° C, 5 ± 1% CO 2 , 95 % RH(Relative Humidity). 9. At the end of the 60 ± 5 min pre-incubation period, transfer the inserts from the upper wells into the lower wells of the 6-well plate. Place the plates back into the incubator (37 ± 1° C, 5 ± 1% CO 2 , 95 % RH) for an overnight pre-incubation (18 ± 3 hr). 10. Place the rest of the assay medium into the refrigerator (5 ± 3 °C). Following the overnight pre-incubation, the test chemicals can be applied to the EpiDerm tissues.
Note: The pre-incubation procedure can be shortened in case of late tissue delivery (e.g. if tissues arrive on Wednesday instead of Tuesday).
2. Approximately 5 minutes before the planned exposure to chemicals, remove the 6-well plates containing the pre-conditioned tissues from the incubator. 3. Evaluate the surface of tissues and remove any moisture using sterile cotton tips. Gently shake the inserts to improve the spreading of the solid on the surface. 9. For test substances with waxy consistency, try to form a flat "cookie like" piece about 8 mm in diameter and place it atop the tissue, which was previously wetted with sterile DPBS. To improve the contact between test substance and tissue, weigh down the "cookie" with a stainless steel or plastic aid. 10. Apply DPBS as the negative control and 5% SDS as the positive control to the control tissues. 11. After dosing the last tissue, transfer all the plates for 35 ± 1 minutes to the humidified incubator (37 ± 1° C, 5 ± 1% CO 2 , 95 % RH). 12. After the 35 ± 1 minute incubation at 37°C remove all the plates from the incubator. Place the plates into the sterile hood and wait until a period of 60 minutes chemical exposure is completed for the first dosed tissue. 13. Afterwards start the washing procedure using the one insert per minute time interval (to insure that the total exposure time for every insert is 60 minutes). 14. Use a wash bottle to rinse the tissues with sterile DPBS. Fill the tissue insert 15 times by using a constant stream of DPBS and empty it (Note: for tissues with a nylon mesh, wash the tissue surface 5 times and remove the mesh carefully with the pointed, sharp forceps. Afterwards, continue with the remaining 10 washes). 15. After the 15th rinse using the wash bottle, completely submerge the insert 3 times in 150 ml DPBS and shake to remove the remainder of the test material. 16. Finally, rinse the tissue insert once from the inside and once from the outside with sterile DPBS. 17. Remove any excess of DPBS from the tissue by gently shaking the insert, and blotting it on the sterile blotting paper. 18. Transfer the blotted tissue inserts to the new 6-well plate previously pre-filled with assay medium. All of these steps (14-18) must be done within 1 min for each insert. 19. After the last tissue is rinsed, carefully dry the surface of each tissue with a sterile cotton tipped swab. 20. Incubate the tissues in the incubator for the next 24 ± 2 hours (37 ± 1° C, 5 ± 1% CO 2 , 95 % RH).
Note: Each assay technician should not test more than 6 test substances including the negative and positive controls in a single testing run (set), to be able follow the protocol as described below
III. Medium exchange -Day 2
1. After the 24 ± 2 hour post-incubation, transfer the inserts into the lower part of the 6-well plate, pre-filled with 0.9 ml of media. Media from upper rows can be collected for analysis of the additional endpoints (cytokines, chemokines etc.). Analysis of the secondary endpoints is optional. 2. Continue with the post-incubation (37 ± 1° C, 5 ± 1% CO 2 , 95 % RH) for another 18 ± 3 hours.
IV. MTT Viability Assay -Day 3
1. Label two 24-well plates with the chemical names or codes. One plate will serve for tissue incubation with MTT and the other for the extraction step. 2. Prepare the MTT solution by thawing the MTT concentrate (5 mg/ml) and diluting it with the MTT diluent. Final concentration of MTT solution is 1 mg/ml. 3. Pipette 300 μL of MTT solution into each well of the 24 well plate. 4. Remove the 6-well plates from incubator, blot the bottom of the inserts on a blotting paper, and transfer them into the 24-well plate pre-filled with MTT. 5. Place the 24-well plate in the incubator (37 ± 1° C, 5 ± 1% CO 2 , 95 % RH) and incubate for 3 hours ± 5 min. Strictly adhere to the 3 hours ± 5 min incubation time to avoid deviation between different MTT readings. 6. When the MTT incubation is complete, use a suction pump to gently aspirate the MTT medium from all the wells. 7. Refill the wells with DPBS and aspirate again. Repeat this rinsing two more times and make sure that tissues are dry after the last aspiration. 8. After the washes transfer the inserts to a new 24-well plate. Immerse the inserts by gently pipetting 2 mL extractant solution (Isopropanol) into each insert. The level will rise above the upper edges of the insert, thus completely submerging the tissues. 9. Seal the 24-well plate (e.g. with Parafilm or using sealing bag) to inhibit extractant evaporation. Extract the MTT from the tissues for at least 2 hours at room temperature with gentle shaking on a plate shaker (~ 120 rpm). Overnight extraction without shaking can also be used. 10. After the extraction period is complete, pierce the inserts with an injection needle or bulb beaded Pasteur pipette and allow the extract to run into the well from which the insert was taken. 11. Discard the punctured insert and pipette the solution in the well up and down three times until it is homogenous. 12. For each tissue, transfer two 200 μL aliquots of the purple formazan solution into a 96-well flat bottom microtiter plate. Transfer the duplicates according to the fixed plate design given in the spreadsheet accompanying this video protocol. For blanks, use isopropanol. 13. Read the optical density (OD) of the MTT extracts in a 96-well plate spectrophotometer using a wavelength of 570 nm (540-580) without a reference filter.
14. Enter the results in the spreadsheet for automatic calculation of the results (Figure 1 The skin irritancy is predicted from the mean viability determined on 3 single tissues and therefore the variability of tissue replicates should be acceptably low. The assay meets the acceptance criterion if the SD calculated from individual % tissue viabilities of the 3 identically treated replicates is <18%.
V. Assay Quality Controls

